Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Hemasphere
|
April 30, 2026
Factors associated with response to rituximab in patients with immune thrombocytopenia
Galina Tsykunova, Eskild Bendix Kristiansen, Tor Henrik Anderson Tvedt, et al.
British Journal of Haematology
|
August 5, 2024
Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway
Christian Fynbo Christiansen, Nickolaj Risbo, Waleed Ghanima, et al.
BMJ Open Diabetes Research & Care
|
January 31, 2018
Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study
Helen Strongman, Solomon Christopher, Maila Majak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 13, 2020
Comorbid disease burden among MS patients 1968-2012: A Swedish register-based cohort study
Kelsi A Smith, Sarah Burkill, Ayako Hiyoshi, et al.
The Knee
|
May 24, 2019
Income change after cruciate ligament injury - A population-based study
Alejandro I Marcano, Richard Nordenvall, Pär Karlsson, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 2, 2019
Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia
Kasper Adelborg, Nickolaj R Kristensen, Mette Nørgaard, et al.
Frontiers in Neurology
|
October 5, 2020
The DQB1<sup>*</sup>03:02 Genotype and Treatment for Pain in People With and Without Multiple Sclerosis
Sarah Burkill, Kelsi A Smith, Pernilla Stridh, et al.
BMJ (Clinical Research Ed.)
|
August 18, 2016
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
Pasi Korhonen, Edith M Heintjes, Rachael Williams, et al.
European Journal of Haematology
|
April 14, 2021
Predictors for and outcomes after bone marrow biopsy in Scandinavian patients with chronic immune thrombocytopenia
Madeleine Andersson Gotschalck, Mette Nørgaard, Nickolaj Risbo, et al.
BMJ Open Diabetes Research & Care
|
August 2, 2017
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study
Helen Strongman, Pasi Korhonen, Rachael Williams, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Hemasphere
|
April 30, 2026
Factors associated with response to rituximab in patients with immune thrombocytopenia
Galina Tsykunova, Eskild Bendix Kristiansen, Tor Henrik Anderson Tvedt, et al.
British Journal of Haematology
|
August 5, 2024
Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway
Christian Fynbo Christiansen, Nickolaj Risbo, Waleed Ghanima, et al.
BMJ Open Diabetes Research & Care
|
January 31, 2018
Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study
Helen Strongman, Solomon Christopher, Maila Majak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 13, 2020
Comorbid disease burden among MS patients 1968-2012: A Swedish register-based cohort study
Kelsi A Smith, Sarah Burkill, Ayako Hiyoshi, et al.
The Knee
|
May 24, 2019
Income change after cruciate ligament injury - A population-based study
Alejandro I Marcano, Richard Nordenvall, Pär Karlsson, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 2, 2019
Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia
Kasper Adelborg, Nickolaj R Kristensen, Mette Nørgaard, et al.
Frontiers in Neurology
|
October 5, 2020
The DQB1<sup>*</sup>03:02 Genotype and Treatment for Pain in People With and Without Multiple Sclerosis
Sarah Burkill, Kelsi A Smith, Pernilla Stridh, et al.
BMJ (Clinical Research Ed.)
|
August 18, 2016
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
Pasi Korhonen, Edith M Heintjes, Rachael Williams, et al.
European Journal of Haematology
|
April 14, 2021
Predictors for and outcomes after bone marrow biopsy in Scandinavian patients with chronic immune thrombocytopenia
Madeleine Andersson Gotschalck, Mette Nørgaard, Nickolaj Risbo, et al.
BMJ Open Diabetes Research & Care
|
August 2, 2017
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study
Helen Strongman, Pasi Korhonen, Rachael Williams, et al.
Page
of 9